NCT05627232 2026-03-12Tazemetostat and Palbociclib With CPX-351for R/R AMLThomas Jefferson UniversityPhase 1 Recruiting24 enrolled
NCT03896269 2026-02-20CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaM.D. Anderson Cancer CenterPhase 1 Recruiting38 enrolled